Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Ajanta Pharma rises after Q4 PAT climbs 18% YoY
Ajanta Pharma rose 3.49% to Rs 3,002.20 after the pharmaceutical company reported healthy Q4 FY26 earnings, driven by steady performance across branded markets.
Ajanta Pharma consolidated net profit rises 18.40% in the March 2026 quarter
Sales rise 21.47% to Rs 1421.64 crore
Ajanta Pharma Q4 net profit rises 18% despite ₹42 crore forex loss; revenue grows 21%
Shares of Ajanta Pharma Ltd ended at ₹2,910.00, up by ₹5.85, or 0.20%, on the BSE.
Q4 Results Live Updates: Tata Tech gains most since listing; CAMS up 6% ahead of earnings call
Q4 Results LIVE Updates: Today is an important day when it comes to results as two big Nifty 50 constituents will be reporting their results today and those are Larsen & Toubro, and Mahindra & Mahindra. For L&T, the company's West Asia exposure and commentary on the same will remain a key talking point, while M&M's demand outlook will also be watched by the street. Along with them, stocks like Hero MotoCorp, Coforge, SRF, Marico, United Breweries, Ajanta Pharma, PNB, Raymond and Shoppers Stop will also be reporting their results today. Follow for all the LIVE updates.
Stock Alert: Wockhardt, Jindal Stainless, Petronet LNG, Manappuram Finance, Aarti Industries
Larsen & Toubro, Mahindra and Mahindra, Punjab National Bank, Marico, Hero Motocorp, Lloyds Metals and Energy, SRF, Coforge, United Breweries, Poonawalla Fincorp, Ajanta Pharma, Emcure Pharmaceuticals, Aadhar Housing Finance, Gallantt Ispat, Jammu and Kashmir Bank, Voltamp Transformers, AAVAS Financiers, Lloyds Engineering Works, Alkyl Amines Chemicals, SJS Enterprises, Shilchar Technologies, GNG Electronics, Gujarat Heavy Chemicals, Aeroflex Industries, Shanthi Gears, Shoppers Stop, Dalmia Bharat Sugar and Industries, Cigniti Technologies, Raymond Realty, Raymond, Shipping Corporation of India Land and Assets, PTC India Financial Services, Spandana Sphoorty Financial, Dolphin Offshore Enterprises (India), CFF Fluid Control, DCW, Automobile Corporation of Goa (ACGL), Paushak, Mafatlal Industries, B Right Realestate, Kothari Petrochem, Foseco Crucible (India), Sutlej Textiles and Industries, Primo Chemicals, Onward Technologies, Kriti Nutrients, Jenburkt Pharma, Kriti Industries ..
USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facility
Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, 2026. The company stated it will respond within the stipulated timeframe, while noting that Form-483 is issued when inspectors observe potential regulatory violations.
Ajanta Pharma's Paithan plant gets five observations from USFDA; stock volatile
The inspection, conducted between April 13 and April 21, 2026, ended with the issuance of a Form 483 carrying five observations.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 13 March 2026
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — HFCL, Cummins India, Ajanta Pharma, Power Finance Corporation, and Kirloskar Oil Engines.
Trade Spotlight: How should you trade Ajanta Pharma, HFCL, Timken India, Linde India, Supreme Industries, and others on March 13?
The market is expected to continue to face risk-off sentiment amid geopolitical tensions. Below are some short-term trading ideas to consider.
Buy Ajanta Pharma; target of Rs 3400: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 06, 2026.
Stocks to watch today: Coforge, L&T, M&M, KEC International, Ajanta Pharma in focus on May 6
Stocks in focus include Bajaj Auto, Brigade Enterprises, Blue Star, Godrej Consumer Products, Hexaware Technologies, Meesho, One 97 Communications, Shree Cement, Radico Khaitan, Raymond Lifestyle, Dhara Rail Projects, KRM Ayurveda, Macobs Technologies, Odyssey Technologies, Stylam Industries.
Kotak Mahindra MF buys Rs 612 crore worth Emcure shares from Bain Capital, promoter sells 2.8% stake in Ajanta Pharma
BC Investments held 3.87 percent stake in Emcure Pharmaceuticals as of March 2026.